Photodynamic therapy activated with cerenkov luminescence from beta-emitting radionuclides

Brad A. Hartl, David L. Boucher, Laura Marcu, Simon R Cherry

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

Abstract

Cerenkov luminescence generated from radionuclides was used as a novel light source for photodynamic therapy. This technique, in conjunction with administration of δ-aminolevulinic acid, was shown to inhibit growth of U-87 glioblastoma cells in vitro.

Original languageEnglish (US)
Title of host publicationOptical Trapping Applications, OTA 2013
StatePublished - 2013
EventOptical Trapping Applications, OTA 2013 - Waikoloa Beach, HI, United States
Duration: Apr 14 2013 → Apr 18 2013

Other

OtherOptical Trapping Applications, OTA 2013
CountryUnited States
CityWaikoloa Beach, HI
Period4/14/13 → 4/18/13

Fingerprint

Aminolevulinic Acid
Photochemotherapy
Glioblastoma
Luminescence
Radioisotopes
radioactive isotopes
therapy
light sources
luminescence
Light
acids
Growth
cells
In Vitro Techniques

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Atomic and Molecular Physics, and Optics

Cite this

Hartl, B. A., Boucher, D. L., Marcu, L., & Cherry, S. R. (2013). Photodynamic therapy activated with cerenkov luminescence from beta-emitting radionuclides. In Optical Trapping Applications, OTA 2013

Photodynamic therapy activated with cerenkov luminescence from beta-emitting radionuclides. / Hartl, Brad A.; Boucher, David L.; Marcu, Laura; Cherry, Simon R.

Optical Trapping Applications, OTA 2013. 2013.

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

Hartl, BA, Boucher, DL, Marcu, L & Cherry, SR 2013, Photodynamic therapy activated with cerenkov luminescence from beta-emitting radionuclides. in Optical Trapping Applications, OTA 2013. Optical Trapping Applications, OTA 2013, Waikoloa Beach, HI, United States, 4/14/13.
Hartl BA, Boucher DL, Marcu L, Cherry SR. Photodynamic therapy activated with cerenkov luminescence from beta-emitting radionuclides. In Optical Trapping Applications, OTA 2013. 2013
Hartl, Brad A. ; Boucher, David L. ; Marcu, Laura ; Cherry, Simon R. / Photodynamic therapy activated with cerenkov luminescence from beta-emitting radionuclides. Optical Trapping Applications, OTA 2013. 2013.
@inproceedings{b37d1a6b3000428dbd4d11e2fdd474ef,
title = "Photodynamic therapy activated with cerenkov luminescence from beta-emitting radionuclides",
abstract = "Cerenkov luminescence generated from radionuclides was used as a novel light source for photodynamic therapy. This technique, in conjunction with administration of δ-aminolevulinic acid, was shown to inhibit growth of U-87 glioblastoma cells in vitro.",
author = "Hartl, {Brad A.} and Boucher, {David L.} and Laura Marcu and Cherry, {Simon R}",
year = "2013",
language = "English (US)",
isbn = "9781557529664",
booktitle = "Optical Trapping Applications, OTA 2013",

}

TY - GEN

T1 - Photodynamic therapy activated with cerenkov luminescence from beta-emitting radionuclides

AU - Hartl, Brad A.

AU - Boucher, David L.

AU - Marcu, Laura

AU - Cherry, Simon R

PY - 2013

Y1 - 2013

N2 - Cerenkov luminescence generated from radionuclides was used as a novel light source for photodynamic therapy. This technique, in conjunction with administration of δ-aminolevulinic acid, was shown to inhibit growth of U-87 glioblastoma cells in vitro.

AB - Cerenkov luminescence generated from radionuclides was used as a novel light source for photodynamic therapy. This technique, in conjunction with administration of δ-aminolevulinic acid, was shown to inhibit growth of U-87 glioblastoma cells in vitro.

UR - http://www.scopus.com/inward/record.url?scp=84887672260&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887672260&partnerID=8YFLogxK

M3 - Conference contribution

AN - SCOPUS:84887672260

SN - 9781557529664

BT - Optical Trapping Applications, OTA 2013

ER -

Access to Document